Lupin informs about updates

04 Oct 2025 Evaluate
With reference to intimation dated July 17, 2025 and with respect to the inspection undertaken by US FDA at Pithampur Unit-2 manufacturing facility from July 8 to July 17, 2025, wherein the inspection was closed with the issuance of a Form-483 with four observations, Lupin has informed that US FDA has determined the inspection classification of this facility as ‘Official Action Indicated (OAI)’. The Company is working with the US FDA to satisfactorily resolve the compliance issues and is committed to be compliant with CGMP standards at all its manufacturing facilities. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2102.50 10.55 (0.50%)
05-Dec-2025 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.00
Dr. Reddys Lab 1276.05
Cipla 1521.20
Zydus Lifesciences 931.85
Lupin 2102.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×